University Of Heidelberg Medical Center
Clinical trials sponsored by University Of Heidelberg Medical Center, explained in plain language.
-
Promising new drug combos aim to improve multiple myeloma treatment before and after transplant
Disease control Recruiting nowThis study tests several new drug combinations for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. The goal is to see if these combinations are safe and work better than current treatments. About 160 adults aged 18 to 70 will take part.
Phase: PHASE2 • Sponsor: University of Heidelberg Medical Center • Aim: Disease control
Last updated May 17, 2026 03:27 UTC
-
New drug combo aims to keep myeloma in check after transplant
Disease control Recruiting nowThis study tests whether adding isatuximab to iberdomide maintenance therapy works better than iberdomide alone for people with newly diagnosed multiple myeloma after a stem cell transplant. About 411 participants will be randomly assigned to one of two treatment groups. The main…
Phase: PHASE3 • Sponsor: University of Heidelberg Medical Center • Aim: Disease control
Last updated May 11, 2026 20:39 UTC